Niagen Bioscience, Inc. (NAGE) support and resistance · P/E 59, rev $61.3M
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
This page maps Niagen Bioscience, Inc. (NAGE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NAGE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NAGE quote page for the session range and the stock page for the full model.
Not investment advice.